{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:57:25Z","timestamp":1740142645516,"version":"3.37.3"},"reference-count":33,"publisher":"FapUNIFESP (SciELO)","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"DOI":"10.1590\/1806-9282.66.7.1172","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T18:49:12Z","timestamp":1601578152000},"page":"1172-1178","source":"Crossref","is-referenced-by-count":2,"title":["Autoimmune encephalitis (AIE)"],"prefix":"10.1590","volume":"66","author":[{"given":"Claudia","family":"Cafalli","sequence":"first","affiliation":[{"name":"Associa\u00e7\u00e3o M\u00e9dica Brasileira,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliane","family":"Amorim","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o M\u00e9dica Brasileira,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavio","family":"Silva","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o M\u00e9dica Brasileira,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mario","family":"Alves Junior","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o M\u00e9dica Brasileira,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio R.","family":"Anhesini","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o M\u00e9dica Brasileira,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8597-5207","authenticated-orcid":false,"given":"Wanderley M.","family":"Bernardo","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o M\u00e9dica Brasileira,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2020,9]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12868-020-00561-9","article-title":"Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?","volume":"21","author":"Li TR","year":"2020","journal-title":"BMC Neurosci"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000696","article-title":"Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment","volume":"7","author":"Mu\u00f1oz-Lopetegi A","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.seizure.2019.12.016","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis with accompanying ovarian teratoma in female patients from East China: Clinical features, treatment, and prognostic outcomes","volume":"75","author":"Zhang L","year":"2020","journal-title":"Seizure"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ana.25655","article-title":"Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1\/CASPR2 Epilepsy","volume":"87","author":"Dubey D","year":"2020","journal-title":"Ann Neurol"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s40425-019-0821-8","article-title":"Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study","volume":"7","author":"Manson G","year":"2019","journal-title":"J Immunother Cancer"},{"key":"ref6","article-title":"Thymoma associated paraneoplastic encephalitis (TAPE), a potential cause of limbic encephalitis","volume":"12","author":"Liu H","year":"2019","journal-title":"BMJ Case Rep"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3988\/jcn.2019.15.3.369","article-title":"Factors Affecting the Response to First-Line Treatments in Patients with Anti-N-Methyl-D-As-partate Receptor Encephalitis","volume":"15","author":"Zhang X","year":"2019","journal-title":"J Clin Neurol"},{"issue":"19","key":"ref8","doi-asserted-by":"crossref","first-page":"e2185","DOI":"10.1212\/WNL.0000000000007475","article-title":"Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis","volume":"92","author":"de Bruijn MAAM","year":"2019","journal-title":"Neurology"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.pedneo.2018.10.006","article-title":"Immunotherapy for anti-NMDA receptor encephalitis: Experience from a single center in Taiwan","volume":"60","author":"Kong SS","year":"2019","journal-title":"Pediatr Neonatol"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s13760-018-1013-x","article-title":"Autoimmune encephalitis and immune therapy: lessons from Argentina","volume":"120","author":"Melamud LI","year":"2020","journal-title":"Acta Neurol Belg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3389\/fneur.2018.00675","article-title":"Cognitive Function Recovery Pattern in Adult Patients with Severe Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Longitudinal Study","volume":"9","author":"Chen Z","year":"2018","journal-title":"Front Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1212\/WNL.0000000000005517","article-title":"Pearls & Oy-sters: Relapse of anti-NMDA receptor encephalitis after prior first- and second-line immunotherapy","volume":"90","author":"Chiang S","year":"2018","journal-title":"Neurology"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/00207454.2017.1408618","article-title":"The gamma-aminobutyric acid-B receptor (GABAB) encephalitis: clinical manifestations and response to immunotherapy","volume":"128","author":"Cui J","year":"2018","journal-title":"Int J Neurosci"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000396","article-title":"Cryptogenic NORSE: Its distinctive clinical features and response to immunotherapy","volume":"4","author":"Iizuka T","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jneuroim.2017.09.005","article-title":"Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes","volume":"312","author":"Wang Y","year":"2017","journal-title":"J Neuroimmunol"},{"key":"ref16","article-title":"Treatment strategies for autoimmune encephalitis","volume":"11","author":"Shin YW","year":"2017","journal-title":"Ther Adv Neurol Disord"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/13803395.2017.1329408","article-title":"Cognitive outcomes following anti-N-methyl-D-aspartate receptor encephalitis: A systematic review","volume":"40","author":"McKeon GL","year":"2018","journal-title":"J Clin Exp Neuropsychol"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00415-017-8407-1","article-title":"Differences in treatment of anti-NMDA receptor encephalitis: results of a worldwide survey","volume":"264","author":"Bartolini L","year":"2017","journal-title":"J Neurol"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/jog.13221","article-title":"Anti-N-methyl-d-aspartate receptor limbic encephalitis associated with mature cystic teratoma of the fallopian tube","volume":"43","author":"Hattori Y","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13256-016-1067-4","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis with an imaging-invisible ovarian teratoma: a case report","volume":"10","author":"Abdul-Rahman ZM","year":"2016","journal-title":"J Med Case Rep"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1007\/s00415-016-8282-1","article-title":"Clinical characteristics and outcomes between children and adults with anti-N-Methyl-D-Aspartate receptor encephalitis","volume":"263","author":"Huang Q","year":"2016","journal-title":"J Neurol"},{"issue":"28","key":"ref22","article-title":"Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures","volume":"95","author":"Li Z","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/dmcn.13159","article-title":"IVIG in Neurology Study Group. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome","volume":"58","author":"Nosadini M","year":"2016","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00404-016-4050-9","article-title":"Treatment principles of ovarian teratoma with anti-N-methyl-D-aspartate receptor encephalitis","volume":"294","author":"Bai Y","year":"2016","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/ane.12575","article-title":"Suspected antibody negative autoimmune limbic encephalitis: outcome of immunotherapy","volume":"135","author":"von Rhein B","year":"2017","journal-title":"Acta Neurol Scand"},{"issue":"1-2","key":"ref26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000441944","article-title":"The Treatment and Follow-Up of Anti-LGI1 Limbic Encephalitis","volume":"75","author":"Yu J","year":"2016","journal-title":"Eur Neurol"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3892\/etm.2015.2866","article-title":"Anti-leucine-rich glioma-inactivated 1 limbic encephalitis: A case report and literature review","volume":"11","author":"Liu J","year":"2016","journal-title":"Exp Ther Med"},{"issue":"10","key":"ref28","first-page":"18927","article-title":"Clinical analysis on anti-N-methyl-D-aspartate receptor encephalitis cases: Chinese experience","volume":"8","author":"Huang X","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"1-2","key":"ref29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000435953","article-title":"Anti-NMDAR Encephalitis of 11 Cases in China - Detailed Clinical, Laboratory and Imagiological Description","volume":"74","author":"Liu J","year":"2015","journal-title":"Eur Neurol"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1684\/epd.2014.0703","article-title":"Effectiveness of multimodality treatment for autoimmune limbic epilepsy","volume":"16","author":"Dubey D","year":"2014","journal-title":"Epileptic Disord"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer MJ","year":"2013","journal-title":"Lancet Neurol"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pediatrneurol.2009.10.003","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis: early treatment is beneficial","volume":"42","author":"Breese EH","year":"2010","journal-title":"Pediatr Neurol"},{"issue":"2 Suppl 1","key":"ref33","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.tmrv.2007.01.002","article-title":"Guidelines on the use of intravenous immune globulin for neurologic conditions","volume":"21","author":"Feasby T","year":"2007","journal-title":"Transfus Med Rev"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ramb\/v66n9\/1806-9282-ramb-66-09-1172.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T02:31:23Z","timestamp":1611455483000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302020000901172&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["S0104-42302020000901172"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.66.7.1172","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"type":"electronic","value":"1806-9282"},{"type":"print","value":"0104-4230"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}